Rtw Investments, LP Alnylam Pharmaceuticals, Inc. Transaction History

Rtw Investments, LP

$6.27 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $6.48 Million - $8.41 Million	-42,803 Reduced 2.54%	1,640,559 $314 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $37.2 Million - $50.9 Million	-292,517 Reduced 14.8%	1,683,362 $275 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $46.7 Million - $61.2 Million	292,517 Added 17.38%	1,975,879 $335 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $217,767 - $301,659	1,717 Added 0.1%	1,683,362 $238 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $4.08 Million - $5.87 Million	43,781 Added 2.67%	1,681,645 $183 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $9.67 Million - $16.1 Million	-129,764 Reduced 7.34%	1,637,864 $189 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $30.5 Million - $37.8 Million	-430,466 Reduced 19.58%	1,767,628 $142 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $89.7 Million - $126 Million	1,362,221 Added 162.97%	2,198,094 $159 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $28.8 Million - $37 Million	396,375 Added 90.19%	835,873 $78.1 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $3.16 Million - $4.45 Million	50,426 Added 12.96%	439,498 $32 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $3.23 Million - $4.52 Million	36,872 Added 10.47%	389,072 $34.1 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $9.36 Million - $11.4 Million	105,971 Added 43.04%	352,200 $34.7 Million
Q1 2018 May 14, 2018	SELL	$115.92 - $148.54 $13 Million - $16.7 Million	-112,545 Reduced 31.37%	246,229 $29.3 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $30.3 Million - $37 Million	-264,564 Reduced 42.44%	358,774 $45.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $45.2 Million - $73.7 Million	623,338	623,338 $73.2 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.87 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$2.96 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.24 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.23 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.16 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account